WashingtonSeven unapproved peptides await a compounding decision.
A Food and Drug Administration advisory panel meets two days to decide whether compounding pharmacies can legally manufacture peptides now barred as unsafe, as unregulated grey-market use surges among Americans.
Health Secretary Robert F. Kennedy Jr. backs looser access; agency staff say safety data is still missing.
Sources: STAT